HKU Scholars Hub: Browsing DSpace

Browsing by Author Yuen, JCH

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中

or enter first few letters:

Showing results 29 to 48 of 75 < previous next >

Title	Author(s)	Issue Date	Views
Immune response during immunoclearance phase of Chinese patients with HBV genotypes B and C Proceeding/Conference:Journal of Hepatology	Yuen, RMF Wong, DKH Chan, CCS Zheng, BJ Yuen, JCH Lai, CL	2005	189
Increase risk of HBeAg-negative chronic hepatitis B with older age at HBeAg seroconversion Proceeding/Conference:Journal of Hepatology	Fung, JYY Lai, CL Wong, DKH Yuen, JCH Yuen, RMF	2009	168
Independent risk factors and predictive score for the development of hepatocellular carcinoma in chronic hepatitis B Proceeding/Conference:Journal of Hepatology	Yuen, RMF Tanaka, Y Fong, DYT Fung, JYY Wong, DKH Yuen, JCH But, D Chan, AOO Wong, BCY Mizokami, M Lai, CL	2008	117
Independent risk factors and predictive score for the development of hepatocellular carcinoma in chronic hepatitis B Journal:Journal of Hepatology	Yuen, MF Tanaka, Y Fong, DYT Fung, J Wong, DKH Yuen, JCH But, DYK Chan, AOO Wong, BCY Mizokami, M Lai, CL	2009	180
Interim analysis of the natural history of chronic hepatitis C genotype 1 and 6 Proceeding/Conference:Hepatology	Seto, WK Lai, CL Fung, JYY Young, JLP Yuen, JCH Wong, DKH Yuen, RMF	2008	89
Interim report on a phase I/IIa, double-blind, randomized, placebo-controlled trial of a novel antiviral agent, LB80380 in Chinese patients with chronic hepatitis B infection Proceeding/Conference:Journal of Hepatology	Yuen, RMF Kim, J Wong, DKH Ngai, WS Yuen, JCH Lai, CL	2004	108
A large case-control study on the predictability of hepatitis B surface antigen levels three years before hepatitis B surface antigen seroclearance Journal:Hepatology	Seto, WK Wong, DKH Fung, J Hung, IFN Fong, DYT Yuen, JCH Tong, T Lai, CL Yuen, MF	2012	191
A large population histology study showing the lack of association between ALT elevation and significant fibrosis in chronic hepatitis B Journal:PLoS ONE	Seto, WK Lai, CL Ip, PPC Fung, J Wong, DKH Yuen, JCH Hung, IFN Yuen, MF	2012	189
Large population study in liver stiffness measurement: prevalence of significant fibrosis and correlation with Liver Biochemistry in Chronic Hepatitis B Proceeding/Conference:Journal of Hepatology	Fung, JYY Lai, CL Yuen, JCH Wong, DKH Cheng, CTK But, DY Yuen, RMF	2007	108
Large scale longitudinal study of chronic hepatitis B patients with hepatitis B surface antigen seroclearance Proceeding/Conference:Journal of Hepatology	Wong, DKH Lai, CL Fung, JYY But, D Hung, IFN Yuen, JCH Fung, FKC Young, JLP Yuen, RMF	2007	97
Liver histology of Asian patients with chronic hepatitis B on prolonged lamivudine therapy Journal:Alimentary Pharmacology and Therapeutics	Yuen, MF Chow, DHF Tsui, K Wong, BCY Yuen, JCH Wong, DKH Lai, CL	2005	166
Long-term lamivudine therapy reduces the risk of long-term complications of chronic hepatitis B infection even in patients without advanced disease Journal:Antiviral Therapy	Yuen, MF Seto, WK Chow, DHF Tsui, K Wong, DKH Ngai, VWS Wong, BCY Fung, J Yuen, JCH Lai, CL	2007	112
Longitudinal study of hepatitis activity and viral replication before and after HBeAg seroconversion in chronic hepatitis B patients infected with genotypes B and C Journal:Journal of Clinical Microbiology	Yuen, MF Fung, SK Tanaka, Y Kato, T Mizokami, M Yuen, JCH Wong, DKH Yuan, HJ Sum, SM Chan, AOO Wong, BCY Lai, CL	2004	129
Low serum HBV DNA levels and development of hepatocellular carcinoma in patients with chronic hepatitis B: A case-control study Journal:Alimentary Pharmacology and Therapeutics	Fung, J Yuen, MF Yuen, JCH Wong, DKH Lai, CL	2007	153
Outcome of lamivudine-resistant chronic hepatitis B after up to 5 years of combination therapy with adefovir Journal:Antiviral Therapy	Seto, WK Liu, K Fung, J Wong, DKH Yuen, JCH Hung, IFN Lai, CL Yuen, MF	2012	75
Phase I/II double-blind, randomized, placebo-controlled study of the novel anti-HBV agent LB80380/ANA380 in patients with chronic HBV infection Proceeding/Conference:Hepatology	Yuen, RMF Kim, J Averett, D Wong, DKH Kim, CR Kerr, B Ngai, WS Yuen, JCH Lai, CL	2004	131
A phase I/IIa, double-blind, randomized, placebo-controlled trial of a novel antiviral agent, LB80380 in patients with chronic hepatitis B infection Proceeding/Conference:Antiviral Research	Yuen, RMF Kim, J Wong, DKH Ngai, WS Yuen, JCH Lai, CL	2003	74
Pin1 over-expression and β-catenin gene mutations are distinct oncogenic events in human hepatocarcinogenesis. Proceeding/Conference:Hong Kong International Cancer Congress, HKICC 2003	Pang, RWC Yuen, JCH Yuen, RMF Lai, CL Kwong, YL Tse, EWC	2003	78
Predictive model for fibrosis and cirrhosis in chronic hepatitis B using liver stiffness measurement Proceeding/Conference:Hepatology	Fung, JYY Lai, CL Fong, DYT Yuen, JCH Wong, DKH Yuen, RMF	2007	108
Predictive value of HBV DNA levels at frequent time points during early and maintenance phase of 5-year laminudine and mutational profiles of reverse transcriptase (RT) and surface (S) genes Proceeding/Conference:Hepatology	Yuen, RMF Wong, DKH Fung, JYY Yuen, JCH Lai, CL	2006	132

Showing results 29 to 48 of 75 < previous next >